Skyhawk Therapeutics

@Skyhawk_Tx

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.

Walth
Vrijeme pridruživanja: siječanj 2018.

Tweetovi

Blokirali ste korisnika/cu @Skyhawk_Tx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Skyhawk_Tx

  1. proslijedio/la je Tweet
    15. sij

    Please RT! A month left to apply for our fantastic paid Summer Program for undergrads. Housing & travel to Denver covered + stipend. Learn and do awesome RNA science in a great place for city/outdoor summer fun. coordination & applicant slots.

    Poništi
  2. proslijedio/la je Tweet
    15. sij

    After a careful deliberation process, we have accepted 80 posters to present at the MIT AIDM Conference. If you are interested in seeing a sneak peek of the posters before the conference, you can review them here:

    Poništi
  3. proslijedio/la je Tweet
    13. sij

    The MIT AIDM Conference has officially reached full capacity! We are excited to welcome our 400+ attendees from 20+ universities & 100+ companies and government organizations in Feb. If you are still interested in participating, sign up for our waitlist:

    Poništi
  4. proslijedio/la je Tweet
    10. sij

    Personally, I think that makes LOTS of sense!

    Poništi
  5. proslijedio/la je Tweet
    8. sij

    Proud to join >200 leaders committed to patients and innovation in making this statement. It’s time to take our industry back!

    Poništi
  6. 6. sij

    Proud to have been selected among these 20 Startups to Watch in Boston in 2020. We expect to make tremendous progress thanks to perfect vision with 2020!! …… via

    Poništi
  7. proslijedio/la je Tweet
    3. sij

    Jim's first breakthrough set the stage for his greatest discovery. , now available on Digital!

    Poništi
  8. proslijedio/la je Tweet

    “Go twice. You won’t regret it, and you’ll never forget it” - Watch Jim Allison: Breakthrough — NOW AVAILABLE on :

    Poništi
  9. proslijedio/la je Tweet
    25. pro 2019.

    Great review of Bill's documentary in , my go-to newspaper when I lived in the U.K. So proud and in awe of our CEO and . Available now on-line, a must-see celebration of scientific research, resilience & perseverance

    Poništi
  10. proslijedio/la je Tweet
    17. pro 2019.

    So proud of our team! This makes 3 positive Phase 3 study readouts in 2019 (ENVISION, ORION w/MedCo and ILLUMINATE)! It's a great day for , therapeutics and PATIENTS most importantly!

    Poništi
  11. proslijedio/la je Tweet

    The story of an amazing discovery from an amazing man. , available 12/24 on :

    Poništi
  12. 20. pro 2019.

    Happy Holidays to you and yours. Taking a short break here to enjoy quality time together after a fantastic year for our company. And yes, socks with our CSO's picture were one of this year's highly fought over Yankee Swap gifts. And no, she didn't manage to win them for herself!

    Poništi
  13. 11. pro 2019.

    So proud of our CEO Bill Haney, who is also an extraordinary filmmaker!

    Poništi
  14. 24. stu 2019.

    A bold prediction: Machine learning will yield new drug candidates within three years via

    Poništi
  15. proslijedio/la je Tweet
    24. stu 2019.

    Celebrating our now Clinical Stage Drug Company, with the first Patient dosed with DF1001, our FIRST internal drug candidate! Thank you to all who made this possible in <4 yrs: our amazing employees, founders, board members & leadership, collaborators, partners, and the patients.

    Poništi
  16. proslijedio/la je Tweet
    21. stu 2019.

    If you’ve never heard of splicing, think of it as the carpentry your body uses to make messenger RNA. See why thinks it can tweak this process with small molecules to treat diseases like and :

    Prikaži ovu nit
    Poništi
  17. proslijedio/la je Tweet
    20. stu 2019.

    Congratulations to on their 2nd global collaboration with , an agreement that takes Skyhawk into fields beyond just Neurology and Oncology, and into Immunology – highlighting that Pharma sees how broadly Skyhawk’s platform applies.

    Poništi
  18. proslijedio/la je Tweet
    20. stu 2019.

    We are very happy to be working with on targets that can impact such a large patient need!

    Poništi
  19. 20. stu 2019.
    Poništi
  20. proslijedio/la je Tweet
    20. stu 2019.

    Just announced: our new collaboration with , covering both oncology AND autoimmune targets. AbbVie is a global leader in treating chronic immune-mediated diseases, and we are delighted to work with their wonderful team!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·